Table of Contents

• FDA PUBLISHES SUBSTANTIAL EVIDENCE PROPOSED RULE [ARCHIVED]
• UPDATE ON DRUG APPROVALS IN FY 97 [ARCHIVED]
• APPLYING PHARMACOKINETICS IN VETERINARY PHARMACEUTICALS REGULATION [ARCHIVED]
  by Marilyn N. Martinez, Ph.D.
• QUALITY STANDARDS FOR THE MANUFACTURE OF ANIMAL DRUGS -- A REPORT FROM VMAC [ARCHIVED]
  by Richard E. Geyer, Esq. Deputy Director, CVM Office of Surveillance and Compliance, Executive Secretary, VMAC
• GOOD GUIDANCE PRACTICES [ARCHIVED]
  by Carol Haley, Ph.D.
• REGULATORY ISSUES IN AGRICULTURAL BIOTECHNOLOGY [ARCHIVED]
• INVESTIGATING DRUG TRANSFER INTO EGGS [ARCHIVED]
  by Dan J. Donoghue, Ph.D.
• OVERVIEW OF FDA PROGRAMS AFFECTING ZOO ANIMAL FEEDS [ARCHIVED]
  by David A. Dzanis, D.V.M., Ph.D., DACVN
• ELECTRONIC FOI READING ROOM NOW AVAILABLE [ARCHIVED]
• CVM SENDS EPIDEMIOLOGIST TO U.K. TO RESEARCH SALMONELLA TYPHIMURIUM DT104 [ARCHIVED]
  by Kathy Hollinger Godon, D.V.M., MPH
• PUBLICATIONS [ARCHIVED]
• TECHNICAL AMENDMENT [ARCHIVED]
• REGULATORY ACTIVITIES [ARCHIVED]
• ABBREVIATED NEW ANIMAL DRUG APPROVALS [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS [ARCHIVED]
• SUPPLEMENTAL ABBREVIATED NEW ANIMAL DRUG APPROVALS [ARCHIVED]